NEW YORK, Aug 6 (Reuters) - Metlife Inc MET.N said on Thursday it assumes U.S. deaths from COVID-19 will rise to about 200,000 by the end of September, but the disease is having minimal overall impact on underwriting.
"We continue to anticipate modest underwriting impacts from COVID-19 on a combined basis, assuming death rises in the U.S. to approximately 200,000 through the third quarter," Chief Financial Officer John McCallion said on a conference call with investors. MetLife released earnings on Wednesday.
(Reporting by Alwyn Scott and Suzanne Barlyn Editing by Chris Reese)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In This StoryMET
Latest Markets Videos
- US STOCKS-Wall St plunges as Snap's bleak forecast sparks selloff
- US STOCKS-Wall Street surges on upbeat retail guidance, easing Fed fears
- All Fed officials backed May rate hike, 'most' saw half-point rises in June and July, minutes show
- Exxon Mobil says looks forward to first LNG export from Mozambique later this year